ASGCT Policy Summit Brings Together Stakeholders to Address Access Issues
By IGT Director of Health Policy & Advocacy John Feore This month, I had the opportunity to participate in the American Society of Cell...
ASGCT Policy Summit Brings Together Stakeholders to Address Access Issues
Congressional Briefing: Realizing the Promise of Gene Therapy: Ensuring Access
ICYMI: Gene therapy provides hope for Huntington’s Disease patients
What They’re Saying: Strong Support for the MVP Act
IGT Congressional Letter and Statement on the Re-Introduction of the MVP Act (H.R. 2666)
Perspective: Advancing Hope for Andrew and Countless Others
Our Healthcare Policies Must Account for the True Value of Transformative Gene Therapies
Congressional Briefing: Realizing the Promise of Gene Therapy through Science & Policy
ICYMI: Cure Sickle Cell Disease by 2030?
A Bold Goal to Cure Sickle Cell Disease by 2030